AU779514C - Methods and compositions for use in gene therapy for treatment of hemophilia - Google Patents

Methods and compositions for use in gene therapy for treatment of hemophilia

Info

Publication number
AU779514C
AU779514C AU48844/02A AU4884402A AU779514C AU 779514 C AU779514 C AU 779514C AU 48844/02 A AU48844/02 A AU 48844/02A AU 4884402 A AU4884402 A AU 4884402A AU 779514 C AU779514 C AU 779514C
Authority
AU
Australia
Prior art keywords
hemophilia
compositions
treatment
methods
gene therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU48844/02A
Other versions
AU4884402A (en
AU779514B2 (en
Inventor
Roland W. Herzog
Katherine High
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Original Assignee
Childrens Hospital of Philadelphia CHOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU64586/98A external-priority patent/AU745386B2/en
Application filed by Childrens Hospital of Philadelphia CHOP filed Critical Childrens Hospital of Philadelphia CHOP
Priority to AU48844/02A priority Critical patent/AU779514C/en
Publication of AU4884402A publication Critical patent/AU4884402A/en
Application granted granted Critical
Publication of AU779514B2 publication Critical patent/AU779514B2/en
Priority to AU2005201735A priority patent/AU2005201735B2/en
Publication of AU779514C publication Critical patent/AU779514C/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU48844/02A 1997-03-14 2002-06-19 Methods and compositions for use in gene therapy for treatment of hemophilia Expired AU779514C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU48844/02A AU779514C (en) 1997-03-14 2002-06-19 Methods and compositions for use in gene therapy for treatment of hemophilia
AU2005201735A AU2005201735B2 (en) 1997-03-14 2005-04-26 Methods and compositions for use in gene therapy for treatment of Hemophilia

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/040711 1997-03-14
AU64586/98A AU745386B2 (en) 1997-03-14 1998-03-12 Methods and compositions for use in gene therapy for treatment of hemophilia
AU48844/02A AU779514C (en) 1997-03-14 2002-06-19 Methods and compositions for use in gene therapy for treatment of hemophilia

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU64586/98A Division AU745386B2 (en) 1997-03-14 1998-03-12 Methods and compositions for use in gene therapy for treatment of hemophilia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005201735A Division AU2005201735B2 (en) 1997-03-14 2005-04-26 Methods and compositions for use in gene therapy for treatment of Hemophilia

Publications (3)

Publication Number Publication Date
AU4884402A AU4884402A (en) 2002-08-08
AU779514B2 AU779514B2 (en) 2005-01-27
AU779514C true AU779514C (en) 2005-12-15

Family

ID=34427358

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48844/02A Expired AU779514C (en) 1997-03-14 2002-06-19 Methods and compositions for use in gene therapy for treatment of hemophilia

Country Status (1)

Country Link
AU (1) AU779514C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114277057B (en) * 2021-07-09 2023-10-13 上海天泽云泰生物医药有限公司 Recombinant adeno-associated viral vectors and methods for treating or preventing hemophilia B

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342390B1 (en) * 1994-11-23 2002-01-29 The United States Of America As Represented By The Secretary Of Health And Human Services Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342390B1 (en) * 1994-11-23 2002-01-29 The United States Of America As Represented By The Secretary Of Health And Human Services Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEN, L ET AL. HUMAN GENE THERAPY 8(2) PP 125-135 (JAN 1997) *
KOEBERL, D.D ET AL PNAS USA 94 PP 1426-1431 (FEB 1997) *

Also Published As

Publication number Publication date
AU4884402A (en) 2002-08-08
AU779514B2 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
IL105914A0 (en) Methods and compositions for in vivo gene therapy
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU9016898A (en) Methods and compositions for treatment of restenosis
AU5800399A (en) Polish composition and method of use
AU4803997A (en) Polymorphisms and new genes in the region of the human hemochromatosis gene
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
AU7261898A (en) Methods for viral inactivation and compositions for use in same
AU4608296A (en) Methods and compositions for treatment of solid tumors in vivo
AU5333298A (en) Compositions and methods for tumour therapy
AU4474000A (en) Virtual reality therapy system and method of use
AU6242498A (en) Methods for treating central and peripheral nerve pain
AU7665396A (en) Recombinant viruses containing mobile genetic elements and methods of use in gene therapy
EP1009433A4 (en) Therapeutic composition and method of treatment
AU779514C (en) Methods and compositions for use in gene therapy for treatment of hemophilia
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU2420101A (en) Method and composition for the treatment of pain
AU9358398A (en) Use of p-glycoprotein (pgp) inhibitors in the treatment of cancer
AU5871898A (en) Microparticles and their use in cancer treatment
AU6592496A (en) Compositions and methods for treating specific gene expression-related diseases and disorders in humans
AU3423397A (en) Therapeutic methods and compositions for use therein
AU3309697A (en) Compositions and methods for treating specific gene expression-related diseases and disorders in humans
AU5778098A (en) Therapeutic substance for use in the treatment of aids and immuno-allergical diseases